Doxorubicin enhances adipogenesis in an FGF2-dependent manner and induces a tumour-promoting secretory phenotype.

Saved in:
Bibliographic Details
Title: Doxorubicin enhances adipogenesis in an FGF2-dependent manner and induces a tumour-promoting secretory phenotype.
Authors: Kreps LM; Cancer Research Program, Ottawa Hospital Research Institute, 501 Smyth Road, Ottawa, Ontario, Canada.; Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, 451 Smyth Road, Ottawa, Ontario, Canada., Yakubovich E; Cancer Research Program, Ottawa Hospital Research Institute, 501 Smyth Road, Ottawa, Ontario, Canada.; Department of Cellular and Molecular Medicine, Faculty of Medicine, University of Ottawa, 451 Smyth Road, Ottawa, Ontario, Canada., Zhao H; Cancer Research Program, Ottawa Hospital Research Institute, 501 Smyth Road, Ottawa, Ontario, Canada., Yimer S; Cancer Research Program, Ottawa Hospital Research Institute, 501 Smyth Road, Ottawa, Ontario, Canada.; Translational and Molecular Medicine Program, Faculty of Medicine, University of Ottawa, 451 Smyth Road, Ottawa, Ontario, Canada., Yang E; Cancer Research Program, Ottawa Hospital Research Institute, 501 Smyth Road, Ottawa, Ontario, Canada., Cruz J; Cancer Research Program, Ottawa Hospital Research Institute, 501 Smyth Road, Ottawa, Ontario, Canada.; Translational and Molecular Medicine Program, Faculty of Medicine, University of Ottawa, 451 Smyth Road, Ottawa, Ontario, Canada., Vanderhyden B; Cancer Research Program, Ottawa Hospital Research Institute, 501 Smyth Road, Ottawa, Ontario, Canada.; Department of Cellular and Molecular Medicine, Faculty of Medicine, University of Ottawa, 451 Smyth Road, Ottawa, Ontario, Canada., Addison CL; Cancer Research Program, Ottawa Hospital Research Institute, 501 Smyth Road, Ottawa, Ontario, Canada.; Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, 451 Smyth Road, Ottawa, Ontario, Canada.; Department of Medicine, University of Ottawa, 451 Smyth Road, Ottawa, Ontario, Canada.
Source: Journal of bone oncology [J Bone Oncol] 2026 Feb 21; Vol. 57, pp. 100754. Date of Electronic Publication: 2026 Feb 21 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101610292 Publication Model: eCollection Cited Medium: Print ISSN: 2212-1366 (Print) Linking ISSN: 22121366 NLM ISO Abbreviation: J Bone Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2212-1366
DOI:10.1016/j.jbo.2026.100754